Dhampur Bio Organics Ltd is Rated Hold

1 hour ago
share
Share Via
Dhampur Bio Organics Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 06 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Dhampur Bio Organics Ltd is Rated Hold

Understanding the Current Rating

The 'Hold' rating assigned to Dhampur Bio Organics Ltd indicates a neutral stance for investors, suggesting that the stock is fairly valued at present and may not offer significant upside or downside in the near term. This rating is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment potential.

Quality Assessment

As of 21 June 2026, Dhampur Bio Organics Ltd exhibits below-average quality metrics. The company has experienced a negative compound annual growth rate (CAGR) of -16.95% in operating profits over the past five years, signalling challenges in sustaining long-term profitability. Additionally, the firm’s ability to service debt remains constrained, with a high Debt to EBITDA ratio of 8.10 times, indicating elevated leverage and potential financial risk. The average Return on Equity (ROE) stands at a modest 2.89%, reflecting limited profitability generated per unit of shareholders’ funds. These factors collectively temper the company’s quality grade and warrant cautious consideration by investors.

Valuation Perspective

Despite the quality concerns, the valuation of Dhampur Bio Organics Ltd appears attractive. The company’s Return on Capital Employed (ROCE) is currently 3.5%, and it trades at an Enterprise Value to Capital Employed ratio of 0.9, which is below the average valuation multiples of its peers. This discount suggests that the stock may be undervalued relative to its capital base and earnings potential. Furthermore, the Price/Earnings to Growth (PEG) ratio is 0.6, indicating that the stock’s price growth is favourable compared to its earnings growth. Such valuation metrics provide a compelling argument for investors seeking value opportunities within the sugar sector.

Financial Trend and Recent Performance

The latest data as of 21 June 2026 shows positive financial momentum for Dhampur Bio Organics Ltd. The company reported its highest quarterly figures in March 2026, with an Operating Profit to Interest ratio of 5.76 times, Profit Before Tax excluding other income at ₹63.76 crores, and a Profit After Tax of ₹46.27 crores. These results underscore an improving operational efficiency and profitability in the short term. Over the past year, the stock has delivered a robust return of 51.81%, while profits have increased by 53.1%, highlighting a strong correlation between earnings growth and stock performance. However, the company’s weak long-term fundamentals and high leverage remain areas of concern.

Technical Analysis

From a technical standpoint, Dhampur Bio Organics Ltd is mildly bullish. The stock has shown consistent upward momentum with a 1-day gain of 1.69%, a 1-week increase of 2.71%, and a 3-month rise of 22.20%. The 6-month and year-to-date returns stand at 54.77% and 48.41%, respectively, reflecting sustained investor interest and positive price action. This technical strength supports the 'Hold' rating by suggesting that while the stock is performing well, it may be approaching a level where gains could moderate.

Market Position and Investor Interest

Dhampur Bio Organics Ltd operates within the sugar sector as a microcap company. Despite its recent performance, domestic mutual funds currently hold no stake in the company. Given that mutual funds typically conduct thorough research and due diligence, their absence may indicate reservations about the stock’s valuation or business prospects. This lack of institutional backing adds a layer of caution for investors considering exposure to this stock.

Summary for Investors

In summary, the 'Hold' rating for Dhampur Bio Organics Ltd reflects a balanced view of the company’s current standing. While the stock benefits from attractive valuation and positive recent financial trends, its below-average quality metrics and high leverage suggest limited upside potential without significant improvement in fundamentals. Investors should weigh these factors carefully, recognising that the stock may be suitable for those seeking value with moderate risk tolerance but may not be ideal for aggressive growth portfolios at this stage.

Fresh entry alert! This Small Cap from Electronics & Appliances sector is already turning heads in our Top 1% club. Get ahead of the market now!

  • - New Top 1% entry
  • - Market attention building
  • - Early positioning opportunity

Get Ahead - View Details →

Investment Considerations Moving Forward

Investors should monitor Dhampur Bio Organics Ltd’s ability to improve its long-term fundamentals, particularly focusing on reducing debt levels and enhancing profitability. Sustained growth in operating profits and improved return ratios would be critical to elevating the company’s quality grade and potentially shifting the rating towards a more favourable outlook. Additionally, increased institutional interest could provide further validation of the stock’s investment merits.

Sector Context

The sugar sector has faced volatility due to fluctuating commodity prices, regulatory changes, and climatic factors affecting crop yields. Dhampur Bio Organics Ltd’s performance must be viewed within this broader context, where external pressures can impact earnings and valuations. The company’s current valuation discount may partly reflect these sector-specific risks, which investors should factor into their decision-making process.

Conclusion

Overall, the 'Hold' rating for Dhampur Bio Organics Ltd as of 06 Feb 2026, supported by current data from 21 June 2026, suggests a cautious but neutral stance. The stock’s attractive valuation and recent financial improvements are balanced by underlying quality concerns and leverage risks. Investors seeking exposure to the sugar sector may consider this stock as part of a diversified portfolio, while closely watching for fundamental improvements and market developments.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News